Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Amiodarone Treatment in the Early Phase of Acute Myocardial Infarction Protects Against Ventricular Fibrillation in a Porcine Model

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Exome-Wide Rare Variant Analyses in Sudden Infant Death Syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. A comprehensive evaluation of the genetic architecture of sudden cardiac arrest

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. A Novel Familial Cardiac Arrhythmia Syndrome with Widespread ST-Segment Depression

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

Vis graf over relationer

Ventricular fibrillation (VF) occurring in the first minutes to hours of acute myocardial infarction (AMI) is a frequent cause of death and treatment options are limited. The aim was to test whether early infusion of amiodarone 10 min after onset of AMI reduced the incidence of VF in a porcine model. Eighteen female Danish landrace pigs were randomized to a control and an amiodarone group. AMI was induced by ligation of the mid-left anterior descending artery for 120 min followed by 60 min of reperfusion. VF occurred in 0/8 pigs treated with amiodarone compared to 7/10 controls (P < 0.01). Amiodarone treatment prolonged RR intervals, reduced dispersion of action potential duration in the infarcted area and mean number of ectopic beats. No negative effects on cardiac output and blood pressure were observed with amiodarone. Amiodarone qualifies as a potential drug candidate to prevent VF in the first minutes to hours of AMI.

OriginalsprogEngelsk
TidsskriftJournal of Cardiovascular Translational Research
Vol/bind12
Udgave nummer4
Sider (fra-til)321-330
Antal sider10
ISSN1937-5387
DOI
StatusUdgivet - aug. 2019

ID: 56384347